|
2025
|
Invention
|
Compositions and methods for treatment of postpartum hemorrhage. The present disclosure relates t... |
|
|
Invention
|
Inhibition of glial cell activation.
Compounds and methods useful for inhibition of glial cell a... |
|
|
Invention
|
Inhibition of glial cell activation. Compounds and methods useful for inhibition of glial cell ac... |
|
|
Invention
|
Methods for treating aberrant behavior and motor activity.
Administration of molindone for the t... |
|
2024
|
Invention
|
Methods for treating aberrant behavior and motor activity. Administration of molindone for the tr... |
|
2022
|
Invention
|
Ccl5 inhibitors. Compounds, pharmaceutically acceptable salts, esters, prodrugs, and pharmaceutic... |
|
|
Invention
|
Cxcl10 inhibitors.
Provided herein are compounds and compositions effective for inhibiting CXCL1... |
|
2021
|
P/S
|
Custom manufacture of cosmetic and aesthetic products, medicated and non-medicated skin care prep... |
|
|
Invention
|
Ccl2 inhibitors. Compounds, pharmaceutically acceptable salts, and pharmaceutical compositions th... |
|
|
Invention
|
Compositions and methods for treating skin conditions, acne form lesions, and acne. A topically a... |
|
|
Invention
|
Compositions and methods for treating skin conditions, acne form lesions, and acne. A topic... |
|
|
Invention
|
Cxcl10 inhibitors. Provided herein are compounds and compositions effective for inhibiting ... |
|
2020
|
P/S
|
Cosmetic preparations for skin care; Non-medicated skin care preparations; Non-medicated skin car... |
|
2019
|
Invention
|
Ccl5 inhibitors.
Compounds, pharmaceutically acceptable salts, esters, prodrugs, and <... |
|
2018
|
Invention
|
Ccl2 inhibitors. Compounds, pharmaceutically acceptable salts, and pharmaceutical compositi... |
|
2017
|
Invention
|
High mobility group b1 protein inhibitors.
Compounds, pharmaceutically acceptable salts, and pha... |
